Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment
ACR/ARHP Annual Meeting 2012: Physicians Find Treatment Options Limited for Scleroderma Bowel Disease
With few proven medical treatments for scleroderma bowel disease, physicians often recommend a lifestyle change for patients as a first treatment option
ACR/ARHP Annual Meeting 2012: What Rheumatologists Need to Know about the New Oral Anticoagulants
A hematologist outlines how the new drugs can help treat coagulation triggered by rheumatological diseases
ACR/ARHP Annual Meeting 2012: Electronic Portals Appeal to Patients
A recent survey found that 75% of patients would use a secure electronic portal to access their medical information
ACR/ARHP Annual Meeting 2012: Children Experience Pain Differently from Adults
Experts say children in pain from rheumatic diseases or other causes may have more discomfort because they can’t downregulate the pain as effectively as adults
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Legal Updates: As Opioids for Pain Treatment Come Under Greater Scrutiny, Controlled Substance Agreements Matter More
These contracts can communicate a physician’s expectations for a pain treatment plan and guidelines for safe use by their patients
Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
Rheumatology Chooses Wisely
ACR identifies five practices, therapies, or procedures physicians and patients should question
The ACR Releases Top 5 Things as Part of Choosing Wisely Campaign
On February 21, the ACR–along with 16 other national medical societies–released its list of Five Things Patients and Physicians Should Question in Rheumatology.
- « Previous Page
- 1
- …
- 662
- 663
- 664
- 665
- 666
- …
- 816
- Next Page »